All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
 
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
 

New England Journal of Medicaine Volume 361:1339-1348, October 1, 2009

Mark B. Landon, M.D., Catherine Y. Spong, M.D., Elizabeth Thom, Ph.D., Marshall W. Carpenter, M.D., Susan M. Ramin, M.D., Brian Casey, M.D., Ronald J. Wapner, M.D., Michael W. Varner, M.D., Dwight J. Rouse, M.D., John M. Thorp, Jr., M.D., Anthony Sciscione, D.O., Patrick Catalano, M.D., Margaret Harper, M.D., George Saade, M.D., Kristine Y. Lain, M.D., Yoram Sorokin, M.D., Alan M. Peaceman, M.D., Jorge E. Tolosa, M.D., M.S.C.E., Garland B. Anderson, M.D., 

ABSTRACT

Background It is uncertain whether treatment of mild gestational diabetes mellitus improves pregnancy outcomes.

Methods Women who were in the 24th to 31st week of gestation and who met the criteria for mild gestational diabetes mellitus (i.e., an abnormal result on an oral glucose-tolerance test but a fasting glucose level below 95 mg per deciliter [5.3 mmol per liter]) were randomly assigned to usual prenatal care (control group) or dietary intervention, self-monitoring of blood glucose, and insulin therapy, if necessary (treatment group). The primary outcome was a composite of stillbirth or perinatal death and neonatal complications, including hyperbilirubinemia, hypoglycemia, hyperinsulinemia, and birth trauma.

View the article on line


 
 
Albuminuria Reduction: The Holy Grail for Kidney Protection

Kidney Int 72: 785-786, 2007.

Katherine R. Tuttle


 
 
American College of Cardiology Poster Presentation: Dr. Michael Ring

Dr.  Michael Ring, recently presented a poster session on behalf of his co-authors: Ken Daratha, Robert Short, Denise Dominik, Lynn Shuler and Katherine Tuttle, for the 2008 American College of Cardiology (ACC) Conference in Chicago, Il. His topic was "Two Year Safety and Revascularization Outcomes Following Coronary Artery Intervention with Bare Metal Stents Versus Strategies of Selective or Predominant Drug Eluting Stents in a Community Setting".

The poster presentation represented the work of their current study completed at Providence Medical Research Center and Sacred Heart Medical Center. The study compared the outcome of individuals who had received a bare metal stent with those who had received drug eluting stents. Patients were tracked for a minimum of 2 years following the placement of the stent, using a regional hospital electronic record.

Read More


 
 

Options :
View Article Map
Notice of Privacy Practices
Providence Sacred Heart Medical Center | Joint Commission Notice | Joint Commission Web Site
© Copyright 2009 Providence Medical Research Center